RekrutujeFaza I/II
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer…
Miasta: Gdańsk, Kraków, Poznań, Tomaszów MazowieckiWiek: od 18 latSponsor: BioNTech SE
W Polsce: Wkrótce rekrutacjaNa świecie: RekrutujeFaza II/III
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic…
Miasta: Bydgoszcz, Jelenia Góra, Kraków, Poznań i 3 inne miastaWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company
RekrutujeFaza III
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Miasta: Kielce, Lublin, Olsztyn, Otwock i 6 innych miastWiek: od 18 latSponsor: Maia Biotechnology Inc.
RekrutujeFaza I/II
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Miasta: Gdańsk, Katowice, Lublin, PoznańWiek: od 18 latSponsor: BioNTech SE
RekrutujeFaza III
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer…
Miasta: Bydgoszcz, Konin, Koszalin, Poznań i 3 inne miastaWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company